Eli Lilly and Company released Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials for adults living with obesity, and announced the medicines are available for self-pay for…
Read more Lilly Releases Zepbound Single-Dose Vials for Adults Living with Obesity/EIN News/ — PALO ALTO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that an…
Read more 180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake – World News Repo… – Medical Marijuana Program ConnectionThe lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him. Terry…
Read more Death in CRISPR gene therapy study sparks search for answers
